Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.34M | 77.14M | 73.14M | 72.18M | 68.28M |
| Total Depreciation and Amortization | 57.54M | 51.63M | 49.61M | 48.49M | 49.40M |
| Total Amortization of Deferred Charges | 3.09M | 8.13M | 8.13M | 8.13M | 6.58M |
| Total Other Non-Cash Items | -5.61M | 7.76M | 7.32M | 6.34M | 2.37M |
| Change in Net Operating Assets | -5.73M | -20.47M | -18.64M | -9.30M | -10.56M |
| Cash from Operations | 132.62M | 124.18M | 119.56M | 125.84M | 116.07M |
| Capital Expenditure | -27.65M | -17.60M | -18.57M | -19.24M | -27.03M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -14.69M | 750.00K | 2.90M | 1.32M | -70.07M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.79M | -9.42M | -8.60M | -12.37M | -7.67M |
| Cash from Investing | -46.13M | -26.28M | -24.28M | -30.28M | -104.77M |
| Total Debt Issued | 66.46M | 44.79M | 44.79M | -12.97M | 72.45M |
| Total Debt Repaid | -126.33M | -100.21M | -111.89M | -57.64M | -57.04M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -9.75M | -6.95M | -4.28M | -1.28M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.16M | -14.81M | -9.65M | -9.65M | -9.65M |
| Cash from Financing | -74.78M | -77.18M | -81.03M | -81.54M | 5.76M |
| Foreign Exchange rate Adjustments | 4.63M | 139.00K | 2.65M | 394.00K | -3.55M |
| Miscellaneous Cash Flow Adjustments | -- | -2.00K | -2.00K | -2.00K | -2.00K |
| Net Change in Cash | 16.34M | 20.87M | 16.90M | 14.41M | 13.51M |